The Publications Office of the EU is in the process of updating some of the content on this website in the light of the withdrawal of the United Kingdom from the European Union. If the site contains content that does not yet reflect the withdrawal of the United Kingdom, it is unintentional and will be addressed.

Services - 620563-2019

30/12/2019    S250    Services - Prior information notice without call for competition - Not applicable 

Spain-Barcelona: Home medical treatment services

2019/S 250-620563

Prior information notice

This notice is for prior information only

Services

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau
Postal address: Sant Antoni M. Claret, 167 — Pabellón Sant Antoni planta baja
Town: Barcelona
NUTS code: ES511
Postal code: 08025
Country: Spain
Contact person: Unidad de Contratación
E-mail: contractacions@santpau.cat
Telephone: +34 935537621
Fax: +34 935537631

Internet address(es):

Main address: www.santpau.cat

Address of the buyer profile: https://contractaciopublica.gencat.cat/ecofin_pscp/AppJava/cap.pscp?reqCode=viewDetail&keyword=sant+pau&idCap=4373006&ambit=&

I.1)Name and addresses
Official name: Liverpool Heart and Chest Hospital NHS Foundation Trust
Postal address: Sant Antoni M. Claret, 167 — Pabellón Sant Antoni planta baja
Town: Barcelona
NUTS code: UKD4
Postal code: 08025
Country: Spain
Contact person: Unidad de Contratación
E-mail: contractacions@santpau.cat
Telephone: +34 935537621
Fax: +34 935537631

Internet address(es):

Main address: http://www.ritmocore-ppi.eu/

I.1)Name and addresses
Official name: Hospital Universitari de Bellvitge de la Gerencia Territorial Metropolitana Sud de l'Institut Català de la Salut
Postal address: Sant Antoni M. Claret, 167 — Pabellón Sant Antoni planta baja
Town: Barcelona
NUTS code: ES511
Postal code: 08025
Country: Spain
Contact person: Unidad de Contratación
E-mail: contractacions@santpau.cat
Telephone: +34 935537621
Fax: +34 935537631

Internet address(es):

Main address: http://www.ritmocore-ppi.eu/

I.1)Name and addresses
Official name: Fundació Assistencial Mutua de Terrassa
Postal address: Sant Antoni M. Claret, 167 — Pabellón Sant Antoni planta baja
Town: Barcelona
NUTS code: ES511
Postal code: 08025
Country: Spain
Contact person: Unidad de Contratación
E-mail: contractacions@santpau.cat
Telephone: +34 935537621
Fax: +34 935537631

Internet address(es):

Main address: http://www.ritmocore-ppi.eu/

I.2)Information about joint procurement
The contract involves joint procurement
In the case of joint procurement involving different countries, state applicable national procurement law:

Spanish/British tender procedure (applicable: law: Spanish). Specific contracts derived from the framework agreement (applicable law: Spanish and British).

The contract is awarded by a central purchasing body
I.3)Communication
Additional information can be obtained from the abovementioned address
I.4)Type of the contracting authority
Other type: Contracting entity, no public administration
I.5)Main activity
Health

Section II: Object

II.1)Scope of the procurement
II.1.1)Title:

Public Procurement of Innovative Solutions to Procure Innovative Services, Enhanced by Digital Technologies, for a Comprehensive and Integrated Management of Patients Using Pacemakers (Ritmocore)

II.1.2)Main CPV code
85141210
II.1.3)Type of contract
Services
II.1.4)Short description:

This PIN announces that the date of publication of contract notice will be January 2020. In particular, we believe that the estimated date of publication of the contract notice could be around January, 10th.

II.1.5)Estimated total value
Value excluding VAT: 19 424 635.05 EUR
II.1.6)Information about lots
This contract is divided into lots: yes
II.2)Description
II.2.1)Title:

Liverpool Heart and Chest Hospital NHS Foundation Trust

Lot No: 1
II.2.2)Additional CPV code(s)
33182000
33182210
33195000
48180000
72000000
85141210
33100000
II.2.3)Place of performance
NUTS code: UKD4
Main site or place of performance:

The contract will be executed at the institution of each member.

II.2.4)Description of the procurement:

This procedure is a public procurement of innovative solutions (PPI). 'Public procurement of innovative solutions (PPI)' means procurement where contracting authorities act as a launch customer of innovative goods or services which are not yet available on a large-scale commercial basis, and may include conformance testing. PPI does not include R&D services. (Reference: ‘Annex E. Specific requirements for innovation procurement (PCP/PPI) supported by Horizon 2020 grants’, within Horizon 2020 – Work Programme 2016-2017).

The procurement will be divided into lots (one for each of the procurers) in order to manage the local refinements of the characteristics of the innovative medical treatment ICT services and solutions to be procured for a comprehensive and integrated care management of patients using a pacemaker. The members of Ritmocore’s buyers group agree to jointly launch a call for tender to procure such services and solutions that outperform existing services and solutions that are available on the market.

More precisely, Ritmocore aims to transform the pacemaker patients care services from a pacemaker implanting hospital centred care service model to a patient centred model and is looking for medical treatment ICT services and solutions enabling the:

(a) personalized pacemaker therapy (provision of adequate devices depending on the patient health conditions, technical support for implantation and extraction, adoption of new emerging technological devices during the term of the contract, co-creation of care protocols);

(b) remote monitoring (support services to adopt the home monitoring programmes for patients with implantable cardiac devices, provision of ‘commented triage’ service for alerts management, administrative services support);

(c) coordinated care (patient access to treatment enabled by the coordination of the different care levels);

(d) patient activation (support for doubts and frequent questions, provision of reliable information, access to technologies approved by reference entities to be used by patients at risk, creation of patient networks, training and support plan for patients and their carers);

(e) change management (in-service training for clinical personnel, training in extraction methodologies and techniques, governance model, model of integration, interoperability and usability, management of technological renewal, model for the relationship between the hospital and the supplier).

The new healthcare model will be implemented in the 4 Ritmocore buyers. Each of them will implement the version of the Ritmocore model responding to their specific circumstances.

The payment in all 4 hospitals will establish a risk sharing in the management of complications with a fixed annual rate according to their catchment population and clinical outcomes obtained. In the fixed rate for a given population, the service supplier guarantees the provision of services for a certain level of annual activity (including the supply of devices); both parties agree on a percentage of annual fluctuation, without changes in the established rate.

Contract implementation will consist of a ‘change management’ phase (which is expected to be completed 12 months after contract signature — during which the innovative services and solutions will be evaluated in real-life operational conditions) and a subsequent ‘operational’ phase up to the end of the contract.

The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate in the PPI and will be able to use them to exploit the full market potential of their innovative solutions i.e. beyond this procurement.

II.2.14)Additional information

This procurement receives funding under the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 727796.

The EU is however not participating as a contracting authority in this procurement.

II.2)Description
II.2.1)Title:

Fundación de Gestión Sanitària del Hospital de la Santa Creu i Sant Pau

Lot No: 2
II.2.2)Additional CPV code(s)
33182000
33182210
33195000
48180000
72000000
85141210
33100000
II.2.3)Place of performance
NUTS code: ES511
Main site or place of performance:

The contract will be executed at the institution of each member.

II.2.4)Description of the procurement:

This procedure is a public procurement of innovative solutions (PPI). 'Public procurement of innovative solutions (PPI)' means procurement where contracting authorities act as a launch customer of innovative goods or services which are not yet available on a large-scale commercial basis, and may include conformance testing. PPI does not include R&D services. (Reference: ‘Annex E. Specific requirements for innovation procurement (PCP/PPI) supported by Horizon 2020 grants’, within Horizon 2020 – Work Programme 2016-2017).

The procurement will be divided into lots (one for each of the procurers) in order to manage the local refinements of the characteristics of the innovative medical treatment ICT services and solutions to be procured for a comprehensive and integrated care management of patients using a pacemaker. The members of Ritmocore’s buyers group agree to jointly launch a call for tender to procure such services and solutions that outperform existing services and solutions that are available on the market.

More precisely, Ritmocore aims to transform the pacemaker patients care services from a pacemaker implanting hospital centred care service model to a patient centred model and is looking for medical treatment ICT services and solutions enabling the:

(a) personalized pacemaker therapy (provision of adequate devices depending on the patient health conditions, technical support for implantation and extraction, adoption of new emerging technological devices during the term of the contract, co-creation of care protocols);

(b) remote monitoring (support services to adopt the home monitoring programmes for patients with implantable cardiac devices, provision of "commented triage" service for alerts management, administrative services support);

(c) coordinated care (patient access to treatment enabled by the coordination of the different care levels);

(d) patient activation (support for doubts and frequent questions, provision of reliable information, access to technologies approved by reference entities to be used by patients at risk, creation of patient networks, training and support plan for patients and their carers);

(e) change management (in-service training for clinical personnel, training in extraction methodologies and techniques, governance model, model of integration, interoperability and usability, management of technological renewal, model for the relationship between the hospital and the supplier).

The new healthcare model will be implemented in the 4 Ritmocore buyers. Each of them will implement the version of the Ritmocore model responding to their specific circumstances.

The payment in all 4 hospitals will establish a risk sharing in the management of complications with a fixed annual rate according to their catchment population and clinical outcomes obtained. In the fixed rate for a given population, the service supplier guarantees the provision of services for a certain level of annual activity (including the supply of devices); both parties agree on a percentage of annual fluctuation, without changes in the established rate.

Contract implementation will consist of a ‘change management’ phase (which is expected to be completed 12 months after contract signature — during which the innovative services and solutions will be evaluated in real-life operational conditions) and a subsequent ‘operational’ phase up to the end of the contract.

The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate in the PPI and will be able to use them to exploit the full market potential of their innovative solutions i.e. beyond this procurement.

II.2.14)Additional information

This procurement receives funding under the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 727796.

The EU is however not participating as a contracting authority in this procurement.

II.2)Description
II.2.1)Title:

Fundació Assistencial Mutua de Terrassa

Lot No: 3
II.2.2)Additional CPV code(s)
33182000
33182210
33195000
48180000
72000000
85141210
33100000
II.2.3)Place of performance
NUTS code: ES511
Main site or place of performance:

The contract will be executed at the institution of each member.

II.2.4)Description of the procurement:

This procedure is a public procurement of innovative solutions (PPI). 'Public procurement of innovative solutions (PPI)' means procurement where contracting authorities act as a launch customer of innovative goods or services which are not yet available on a large-scale commercial basis, and may include conformance testing. PPI does not include R&D services. (Reference: ‘Annex E. Specific requirements for innovation procurement (PCP/PPI) supported by Horizon 2020 grants’, within Horizon 2020 – Work Programme 2016-2017).

The procurement will be divided into lots (one for each of the procurers) in order to manage the local refinements of the characteristics of the innovative medical treatment ICT services and solutions to be procured for a comprehensive and integrated care management of patients using a pacemaker. The members of Ritmocore’s buyers group agree to jointly launch a call for tender to procure such services and solutions that outperform existing services and solutions that are available on the market.

More precisely, Ritmocore aims to transform the pacemaker patients care services from a pacemaker implanting hospital centred care service model to a patient centred model and is looking for medical treatment ICT services and solutions enabling the:

(a) personalized pacemaker therapy (provision of adequate devices depending on the patient health conditions, technical support for implantation and extraction, adoption of new emerging technological devices during the term of the contract, co-creation of care protocols);

(b) remote monitoring (support services to adopt the home monitoring programmes for patients with implantable cardiac devices, provision of ‘commented triage’ service for alerts management, administrative services support);

(c) coordinated care (patient access to treatment enabled by the coordination of the different care levels);

(d) patient activation (support for doubts and frequent questions, provision of reliable information, access to technologies approved by reference entities to be used by patients at risk, creation of patient networks, training and support plan for patients and their carers);

(e) change management (in-service training for clinical personnel, training in extraction methodologies and techniques, governance model, model of integration, interoperability and usability, management of technological renewal, model for the relationship between the hospital and the supplier).

The new healthcare model will be implemented in the four Ritmocore buyers. Each of them will implement the version of the Ritmocore model responding to their specific circumstances.

The payment in all 4 hospitals will establish a risk sharing in the management of complications with a fixed annual rate according to their catchment population and clinical outcomes obtained. In the fixed rate for a given population, the service supplier guarantees the provision of services for a certain level of annual activity (including the supply of devices); both parties agree on a percentage of annual fluctuation, without changes in the established rate.

Contract implementation will consist of a ‘change management’ phase (which is expected to be completed 12 months after contract signature — during which the innovative services and solutions will be evaluated in real-life operational conditions) and a subsequent ‘operational’ phase up to the end of the contract.

The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate in the PPI and will be able to use them to exploit the full market potential of their innovative solutions i.e. beyond this procurement

II.2.14)Additional information

This procurement receives funding under the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 727796.

The EU is however not participating as a contracting authority in this procurement.

II.2)Description
II.2.1)Title:

Hospital Universitari de Bellvitge de la Gerencia Territorial Metropolitana Sud de l'Institut Català de la Salut

Lot No: 4
II.2.2)Additional CPV code(s)
33182000
33182210
33195000
48180000
72000000
85141210
33100000
II.2.3)Place of performance
NUTS code: ES511
Main site or place of performance:

The contract will be executed at the institution of each member.

II.2.4)Description of the procurement:

This procedure is a public procurement of innovative solutions (PPI). 'Public procurement of innovative solutions (PPI)' means procurement where contracting authorities act as a launch customer of innovative goods or services which are not yet available on a large-scale commercial basis, and may include conformance testing. PPI does not include R&D services. (Reference: ‘Annex E. Specific requirements for innovation procurement (PCP/PPI) supported by Horizon 2020 grants’, within Horizon 2020 – Work Programme 2016-2017).

The procurement will be divided into lots (one for each of the procurers) in order to manage the local refinements of the characteristics of the innovative medical treatment ICT services and solutions to be procured for a comprehensive and integrated care management of patients using a pacemaker. The members of Ritmocore’s buyers group agree to jointly launch a call for tender to procure such services and solutions that outperform existing services and solutions that are available on the market.

More precisely, Ritmocore aims to transform the pacemaker patients care services from a pacemaker implanting hospital centred care service model to a patient centred model and is looking for medical treatment ICT services and solutions enabling the:

(a) personalized pacemaker therapy (provision of adequate devices depending on the patient health conditions, technical support for implantation and extraction, adoption of new emerging technological devices during the term of the contract, co-creation of care protocols);

(b) remote monitoring (support services to adopt the home monitoring programmes for patients with implantable cardiac devices, provision of ‘commented triage’ service for alerts management, administrative services support);

(c) coordinated care (patient access to treatment enabled by the coordination of the different care levels);

(d) patient activation (support for doubts and frequent questions, provision of reliable information, access to technologies approved by reference entities to be used by patients at risk, creation of patient networks, training and support plan for patients and their carers);

(e) change management (in-service training for clinical personnel, training in extraction methodologies and techniques, governance model, model of integration, interoperability and usability, management of technological renewal, model for the relationship between the hospital and the supplier).

The new healthcare model will be implemented in the 4 Ritmocore buyers. Each of them will implement the version of the Ritmocore model responding to their specific circumstances.

The payment in all 4 hospitals will establish a risk sharing in the management of complications with a fixed annual rate according to their catchment population and clinical outcomes obtained. In the fixed rate for a given population, the service supplier guarantees the provision of services for a certain level of annual activity (including the supply of devices); both parties agree on a percentage of annual fluctuation, without changes in the established rate.

Contract implementation will consist of a ‘change management’ phase (which is expected to be completed 12 months after contract signature — during which the innovative services and solutions will be evaluated in real-life operational conditions) and a subsequent ‘operational’ phase up to the end of the contract.

The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate in the PPI and will be able to use them to exploit the full market potential of their innovative solutions i.e. beyond this procurement

II.2.14)Additional information

This procurement receives funding under the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 727796.

The EU is however not participating as a contracting authority in this procurement.

II.3)Estimated date of publication of contract notice:
10/01/2020

Section IV: Procedure

IV.1)Description
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no

Section VI: Complementary information

VI.5)Date of dispatch of this notice:
27/12/2019